1Marcellin P, Chang T I, Lim S G, et al. AdefovirdipioXil for thetreatment of hepatitis B e antigen-positive chronic hepatitis B[J]. N EnglJ Med, 2003, 348: 808.
3Marcellin P, Chang TT, Llm SG, et al. Adefovir dipivoxil for the treatment of hepatitis B e antigen-positive chronic hepatitis B[J]. N Engl J Med, 2003, 348(9):808-816.
4Hadziyannis S J, Tassopoulos NC, Heathcote E J, et al.Long-term therapy with adefovir dipivoxil for HBeAgnegative chronic hepatitis B [J]. N Engl J Med, 2005,352(26):2673-2681.
5Peters MG, Hann Hw H, Martin P, et al. Adefovir dipivoxil alone or in combination with lamivudine in patients with lamivudine-resistant chronic hepatitis B[J]. Gastroenterology, 2004, 126(1):91-101.
6Delmas J, Schorr O, Jamard C, et al. Inhibitory effect of adefovir on viral DNA synthesis and covalently closed circular DNA formation in duck hepatitis B virus-infected hepatocytes in vivo and in vitro [J]. Antimicrob A gents Chemother, 2002, 46(2):425-433.
7Angus P, Vaughan R, Xiong S, et al. Resistance to adefovir dipivoxil therapy associated with the selection of a novel mutation in the HBV polymerase[J]. Gastroenterology, 2003, 125(2):292-297.
8Villeneuve JP, Durantel D, Durantel S, et al. Selection of a hepatitis B virus strain resistant to adefovir in a liver transplantation patient[J]. J Hepatol, 2003, 39(6):1085-1089.
9Izzedine H, Hulot JS, Launay-Vacher V, et al. Renal safety of adefovir dipivoxil in patients with chronic hepatitis B: two double-blind, randomized, placebo-controlled studies[J]. Kidney Int, 2004, 66(3):1153-1158.
10Hadziyannis S, Tassopoulos N, Chang T, et al. Three year study of adefovir dipivoxil(ADV) demonstrates sustained efficacy in presumed precore mutant hepatitis B patients in a long term safety and efficacy study [J], J Hepato, 2004, 40(Suppl 1): 17.
